BioCentury
ARTICLE | Clinical News

ATx08-001: Phase II started

February 28, 2011 8:00 AM UTC

Aestus began a double-blind, placebo-controlled Phase II trial to evaluate low- and high-doses of oral ATx08-001 in about 60 patients. Aestus has exclusive, worldwide rights to ATx08-001 from Astellas...